GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Argent Biopharma Ltd (ASX:RGT) » Definitions » PB Ratio

Argent Biopharma (ASX:RGT) PB Ratio : 9.46 (As of Jun. 04, 2024)


View and export this data going back to 2006. Start your Free Trial

What is Argent Biopharma PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-06-04), Argent Biopharma's share price is A$0.35. Argent Biopharma's Book Value per Share for the quarter that ended in Dec. 2023 was A$0.04. Hence, Argent Biopharma's PB Ratio of today is 9.46.

The historical rank and industry rank for Argent Biopharma's PB Ratio or its related term are showing as below:

ASX:RGT' s PB Ratio Range Over the Past 10 Years
Min: 1.77   Med: 5.01   Max: 63.42
Current: 9.46

During the past 13 years, Argent Biopharma's highest PB Ratio was 63.42. The lowest was 1.77. And the median was 5.01.

ASX:RGT's PB Ratio is ranked worse than
93.18% of 953 companies
in the Drug Manufacturers industry
Industry Median: 1.93 vs ASX:RGT: 9.46

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Argent Biopharma was 30.80% per year. The lowest was -50.30% per year. And the median was -28.95% per year.

Back to Basics: PB Ratio


Argent Biopharma PB Ratio Historical Data

The historical data trend for Argent Biopharma's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Argent Biopharma PB Ratio Chart

Argent Biopharma Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.76 10.15 6.20 7.48 -

Argent Biopharma Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.34 7.48 - - 12.84

Competitive Comparison of Argent Biopharma's PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Argent Biopharma's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Argent Biopharma's PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Argent Biopharma's PB Ratio distribution charts can be found below:

* The bar in red indicates where Argent Biopharma's PB Ratio falls into.



Argent Biopharma PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Argent Biopharma's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Dec. 2023)
=0.35/0.037
=9.46

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Argent Biopharma  (ASX:RGT) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Argent Biopharma PB Ratio Related Terms

Thank you for viewing the detailed overview of Argent Biopharma's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Argent Biopharma (ASX:RGT) Business Description

Traded in Other Exchanges
Address
295 Rokeby Road, Suite 1, Subiaco, WA, AUS, 6008
MGC Pharmaceuticals Ltd is a biopharma company with a Nature to Medicine strategy at the forefront of the emerging phytocannabinoid and plant-derived medicine markets. The company's mission is to build an innovative, global bio-pharma company providing standardized, affordable plant-derived medicines of the highest regulatory compliance for targeted global markets.

Argent Biopharma (ASX:RGT) Headlines